Par Drugs & Chemicals Ltd

Par Drugs & Chemicals Ltd Share Price Today: Live Updates & Key Insights

Get insights on Par Drugs & Chemicals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Par Drugs & Chemicals Ltd Share Price Chart

Par Drugs & Chemicals Ltd Fundamentals

Traded Volume: 8,740

Market Cap(Cr): 113

Avg Traded Price 93.47

1 Year return -67.22%

Upper Circuit 94.9

Lower Circuit 92

P/E TTM 12.00

P/B Ratio 8.00

Traded Value(Cr) 8.06

EPS TTM 7.872

Book value 7.872

Dividend 0.00%

Par Drugs & Chemicals Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Par Drugs & Chemicals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Par Drugs & Chemicals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -6.56%

1M -9.14%

3M -6.84%

1Y -67.22%

YTD -55.29%

Par Drugs & Chemicals Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Par Drugs & Chemicals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 5179.00

Day Before Yesterday 7155.00

1W Avg 9907.80

1M Avg 6984.24

3M Avg 8174.87

Par Drugs & Chemicals Ltd Technical Details

Par Drugs & Chemicals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 91

Support 2 90

Support 3 88

Pivot Point : 93

Resistance 1 94

Resistance 2 96

Resistance 3 97

Par Drugs & Chemicals Ltd Corporate Actions

Par Drugs & Chemicals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Par Drugs & Chemicals Ltd’s capital allocation strategies.

All

Ex-Date 22-Nov-2021 Type D Description 1.25/share@12.50% Record Date 23-Nov-2021 Ratio 12.50

Ex-Date 27-Apr-2021 Type B Description share@1:1 Record Date 28-Apr-2021 Ratio 1:1

Ex-Date 10-Jul-2020 Type D Description 1.25/share@12.50% Record Date - Ratio 12.50

Ex-Date 22-Nov-2019 Type D Description 1.25/share@12.50% Record Date 25-Nov-2019 Ratio 12.50

Dividends

Announcement Date 22-Nov-2021 Ex Dividend Date 22-Nov-2021 Dividend(%) 13

Announcement Date 10-Jul-2020 Ex Dividend Date 10-Jul-2020 Dividend(%) 13

Announcement Date 22-Nov-2019 Ex Dividend Date 22-Nov-2019 Dividend(%) 13

Bonus

Record Date 28-Apr-2021 Ex-Bonus Date 27-Apr-2021 Ratio 1:1

Splits

No Split has been declared by PAR

Others

Rights No Rights has been declared by PAR

Par Drugs & Chemicals Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Par Drugs & Chemicals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Par Drugs & Chemicals Ltd's relative performance and valuation against major competitors.

Stock Name Tyche Industries Ltd ₹120.00 (-0.83%) M. Cap (Cr) 1.23 1 Yr Return (%) -36.59% P/E (TTM) 12.73 PB Ratio 0.91

Stock Name Bal Pharma Ltd ₹76.57 (-1.51%) M. Cap (Cr) 1.22 1 Yr Return (%) -43.07% P/E (TTM) 17.86 PB Ratio 1.57

Stock Name Denis Chem Lab Ltd ₹85.00 (-2.98%) M. Cap (Cr) 1.18 1 Yr Return (%) -46.22% P/E (TTM) 16.71 PB Ratio 1.41

Stock Name Par Drugs & Chemicals Ltd ₹92.23 (-0.45%) M. Cap (Cr) 1.13 1 Yr Return (%) -67.22% P/E (TTM) 11.72 PB Ratio 1.17

Stock Name Curis Lifesciences Ltd ₹137.50 (+2.57%) M. Cap (Cr) 1.11 1 Yr Return (%) NaN% P/E (TTM) 18.21 PB Ratio 5.23

Stock Name Aptus Pharma Ltd ₹160.50 (+4.39%) M. Cap (Cr) 1.10 1 Yr Return (%) NaN% P/E (TTM) 35.52 PB Ratio 12.47

Stock Name Mercury Laboratories Ltd ₹873.00 (+2.98%) M. Cap (Cr) 1.05 1 Yr Return (%) -5.42% P/E (TTM) 21.32 PB Ratio 1.96

Par Drugs & Chemicals Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Par Drugs & Chemicals Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 16.16 Mar 2024 20.25 Mar 2023 13.38 Mar 2022 7.62 Mar 2021 12.09

PARTICULARS Investing Activities Mar 2025 -25.24 Mar 2024 -5.84 Mar 2023 -7.34 Mar 2022 -3.02 Mar 2021 0.05

PARTICULARS Financing Activities Mar 2025 0.00 Mar 2024 0.00 Mar 2023 0.00 Mar 2022 -9.55 Mar 2021 1.65

PARTICULARS Net Cash Flow Mar 2025 -9.08 Mar 2024 14.41 Mar 2023 6.04 Mar 2022 -4.96 Mar 2021 13.78

Par Drugs & Chemicals Ltd Shareholding Pattern

This shows the ownership breakdown of Par Drugs & Chemicals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 73.37%

Public 26.63%

Other Institutions 0%

FII null%

Mutual Funds null%

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name Par Drugs and Chemicals Private Limited at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name was changed to Par Drugs and Chemicals Limited on 5 November 2018.The Company is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as bulk drugs or bulk actives are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facility for different products. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Company supplies its products to approximately 16 countries, including both direct and indirect exports. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019. In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.

Chairman & Managing Director

FALGUN VALLABHBHAI SAVANI

Registered office 805 Dwarkesh Complex, RC Dutt Road Alkapuri, Vadodara, Gujarat, 390007

FAX :91-265-2332018

Background

Incorporation Year 1999

Face Value ₹10.00

Market Lot 1

Par Drugs & Chemicals Ltd Latest News

VIEW MORE NEWS

FAQs on Par Drugs & Chemicals Ltd